ALK+
MHRA to extend EpiPen expiry dates to tackle shortages
October 18, 2018Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …
Roche’s Alecensa receives second FDA Breakthrough Therapy Designation
October 4, 2016Manufacturing and Production ALK+, Alecensa, FDA, Roche, alk, crizotinib
Alecensa has been designated as a breakthrough therapy, which will speed up the process towards FDA approval, should clinical trials …
Promising signs for Novartis’ lung cancer drug
June 4, 2013Sales and Marketing ALK+, ASCO, LDK378, NSCLC, Novartis
Targeted lung cancer treatment LDK378 has been shown to help patients with the ALK+ gene mutation in a phase I trial.Novartis’ drug …
